54 related articles for article (PubMed ID: 22495391)
1. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.
Lin G; Wang J; Lao X; Wang J; Li L; Li S; Zhang J; Dong Y; Chang AE; Li Q; Li S
J Immunother; 2012 May; 35(4):337-43. PubMed ID: 22495391
[TBL] [Abstract][Full Text] [Related]
2. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
Pan QZ; Liu Q; Zhou YQ; Zhao JJ; Wang QJ; Li YQ; Tang Y; Gu JM; He J; Chen SP; Weng DS; Xia JC
Cancer Immunol Immunother; 2020 May; 69(5):825-834. PubMed ID: 32060687
[TBL] [Abstract][Full Text] [Related]
3. Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells.
Wang Y; Dai H; Li H; Lv H; Wang T; Fu X; Han W
Clin Dev Immunol; 2011; 2011():621414. PubMed ID: 21455282
[TBL] [Abstract][Full Text] [Related]
4. Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review.
Eralp Y; Ates U
Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896948
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View.
Nenu I; Toadere TM; Topor I; Țichindeleanu A; Bondor DA; Trella ȘE; Sparchez Z; Filip GA
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892997
[TBL] [Abstract][Full Text] [Related]
6. Diabetic complications and prospective immunotherapy.
Reynolds L; Luo Z; Singh K
Front Immunol; 2023; 14():1219598. PubMed ID: 37483613
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Strecker MI; Wlotzka K; Strassheimer F; Roller B; Ludmirski G; König S; Röder J; Opitz C; Alekseeva T; Reul J; Sevenich L; Tonn T; Wels WS; Steinbach JP; Buchholz CJ; Burger MC
Oncoimmunology; 2022; 11(1):2127508. PubMed ID: 36249274
[TBL] [Abstract][Full Text] [Related]
8. Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells.
Zúñiga TM; Baker FL; Smith KA; Batatinha H; Lau B; Gustafson MP; Katsanis E; Simpson RJ
Front Immunol; 2022; 13():938106. PubMed ID: 36189306
[TBL] [Abstract][Full Text] [Related]
9. Combination of OX40 Co-Stimulation, Radiotherapy, and PD-1 Inhibition in a Syngeneic Murine Triple-Negative Breast Cancer Model.
Han MG; Wee CW; Kang MH; Kim MJ; Jeon SH; Kim IA
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681672
[TBL] [Abstract][Full Text] [Related]
10. The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications.
Sajid M; Liu L; Sun C
Front Immunol; 2022; 13():887186. PubMed ID: 35669776
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Early Peripheral Immune Responses in Patients with Sepsis and Septic Shock.
Beltrán-García J; Osca-Verdegal R; Jávega B; Herrera G; O'Connor JE; García-López E; Casabó-Vallés G; Rodriguez-Gimillo M; Ferreres J; Carbonell N; Pallardó FV; García-Giménez JL
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327327
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity.
Piekarska K; Urban-Wójciuk Z; Kurkowiak M; Pelikant-Małecka I; Schumacher A; Sakowska J; Spodnik JH; Arcimowicz Ł; Zielińska H; Tymoniuk B; Renkielska A; Siebert J; Słomińska E; Trzonkowski P; Hupp T; Marek-Trzonkowska NM
Nat Commun; 2022 Feb; 13(1):856. PubMed ID: 35165293
[TBL] [Abstract][Full Text] [Related]
13. Adoptive cell therapies in thoracic malignancies.
Lasvergnas J; Naigeon M; Chouahnia K; Zelek L; Chaput N; Duchemann B
Cancer Immunol Immunother; 2022 Sep; 71(9):2077-2098. PubMed ID: 35129636
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of Treg Cells to Inhibit Osteoclastogenesis in Gorham-Stout Disease.
Rossi M; Rana I; Buonuomo PS; Battafarano G; De Martino V; D'Agostini M; Porzio O; Cipriani C; Minisola S; De Vito R; Vecchio D; Gonfiantini MV; Jenkner A; Bartuli A; Del Fattore A
Front Cell Dev Biol; 2021; 9():706596. PubMed ID: 34513837
[TBL] [Abstract][Full Text] [Related]
15. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GL; Hale JDF; Kemp RA
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients.
Stanojković TP; Matić IZ; Petrović N; Stanković V; Kopčalić K; Besu I; Đorđić Crnogorac M; Mališić E; Mirjačić-Martinović K; Vuletić A; Bukumirić Z; Žižak Ž; Veldwijk M; Herskind C; Nikitović M
Sci Rep; 2020 Nov; 10(1):19002. PubMed ID: 33149212
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 as an Emerging Player in Tumor Microenvironment.
Xue W; Yan D; Kan Q
J Cancer; 2019; 10(9):2074-2082. PubMed ID: 31205568
[TBL] [Abstract][Full Text] [Related]
19. A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice.
Ryan JM; Mittal P; Menoret A; Svedova J; Wasser JS; Adler AJ; Vella AT
Cancer Immunol Immunother; 2018 Apr; 67(4):605-613. PubMed ID: 29327109
[TBL] [Abstract][Full Text] [Related]
20. T cell subsets: an integral component in pathogenesis of rheumatic heart disease.
Toor D; Sharma N
Immunol Res; 2018 Feb; 66(1):18-30. PubMed ID: 29170852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
